Cash fell 98.5% to NZ$3K as revenue halved on COVID-19

Cash and equivalents collapsed 98.5% to NZ$0.003m from NZ$0.198m, and net cash outflow from operating activities widened to NZ$0.482m from NZ$0.150m, a roughly threefold deterioration. A small NZ$0.053m of borrowings has appeared on the balance sheet where there was none a year ago.

Revenue fell 47.6% to NZ$0.6m, with management attributing the decline to COVID-19 disruption and an inventory impairment. Despite that, the reported loss narrowed: PBT improved 21.0% to a NZ$0.9m loss and NPAT improved 26.0% to a NZ$0.5m loss, so cost actions outran the revenue drop on the P&L.

Total equity fell 36.1% to NZ$1.6m and total assets fell 23.1% to NZ$3.1m, while liabilities were broadly flat. ROE weakened to -27.8% from -24.0%.

• A NZ$3K closing cash balance against a NZ$0.5m annual operating cash outflow means the business cannot self-fund another year at this run-rate. The newly drawn NZ$0.053m borrowing is small relative to the burn, so external funding or a sharp working-capital release is required to keep operating. This matters because it shifts the read from "loss-narrowing turnaround" to a funding-event question.

• The narrower loss does not reflect better cash generation. PBT improved 21.0% and NPAT 26.0%, but operating cash outflow worsened 221.3%, so the income-statement improvement is not converting. Inventories fell NZ$0.2m to NZ$0.7m, partly via the disclosed stock impairment, which helps reported costs but does not generate sustainable cash.

• Revenue base is now very small. At NZ$0.6m of annual revenue against NZ$1.4m of liabilities and NZ$1.6m of equity, the cost base is no longer covered by sales, and the loss is large relative to the revenue line. The COVID-19 explanation is plausible, but the FY20 result was already loss-making, so this is the second consecutive year of material losses rather than a one-year disruption.

Commentary references an updated pricing strategy and a relaunched marketing campaign at AFCLV intended to "enable future revenue" growth, but no order book, pipeline value, or revenue target accompanies that language.

The HY21 disclosure shows H1 revenue of NZ$288K and an H1 net loss of NZ$317K, implying H2 revenue of roughly NZ$359K and a substantially smaller H2 loss. That is a modestly better second half, but the trajectory still leaves FY21 revenue below FY20, and there is no disclosed evidence that the underlying demand environment has normalised. With cash effectively exhausted, the gap that matters is between management's revenue-recovery plan and the funding runway available to execute it.

The reported tax line lifts NPAT growth above PBT growth by 5.0 percentage points, but both effective tax rates round to 0.0% on losses, so the gap is mechanical rather than indicative of operating tax leakage. The cleaner read is PBT, which improved 21.0% on revenue that fell 47.6% — driven by cost reduction and an inventory impairment rather than trading momentum.

Cash quality is the bigger flag. FCF pre-lease was NZ$-0.5m against an NPAT loss of NZ$-0.5m, so cash conversion did not deteriorate versus the reported loss in isolation, but operating cash outflow widened materially in absolute terms while NPAT improved. That divergence indicates the income-statement gains are not yet earning their way through working capital. Capex was nil, so there is no capex story to fund or defer; the burn is operating. With equity down 36.1% in a single year and cash near zero, the balance sheet is no longer absorbing further losses comfortably.

This briefing cannot assess management's funding plan, the durability of the H2 revenue uptick, or whether the inventory impairment fully cleans the stock position.